Olivier Lada

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients #

Rami Moucari, Vincent Mackiewicz, Olivier Lada et al. · Hepatology · 2008 · 482 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study

Rami Moucari, Anneke Korevaar, Olivier Lada et al. · Journal of Hepatology · 2009 · 186 citations

Medicine, Immunology, Infectious Diseases +15

IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C

Tarik Asselah, Simon De Muynck, Philippe Broët et al. · Journal of Hepatology · 2011 · 182 citations

Medicine, Immunology, Pharmacology +14

Coexistence of Hepatitis B Surface Antigen (HBs Ag) and Anti-HBs Antibodies in Chronic Hepatitis B Virus Carriers: Influence of “a” Determinant Variants

Olivier Lada, Yves Benhamou, Thierry Poynard et al. · Journal of Virology · 2006 · 163 citations · Full text

Life Sciences, Genetics, Infectious Diseases +13

Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C

Ana Carolina Cardoso, Roberto José de Carvalho‐Filho, Christiane Stern et al. · Liver International · 2011 · 148 citations

Medicine, Infectious Diseases, Internal Medicine +17